Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-17 Sale | 2025-03-18 12:27 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 183 | $24.82 | $4,543 | 47,955 (Direct) | View |
| 2025-03-05 Sale | 2025-03-06 5:17 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,569 | $25.1 | $139,789 | 218,866 (Indirect Direct) | View |
| 2025-02-11 Sale | 2025-02-12 1:59 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 363 | $28.54 | $10,360 | 83,945 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:20 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 695 | $29.52 | $20,519 | 224,435 (Indirect Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:18 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 695 | $29.52 | $20,519 | 84,050 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:15 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 546 | $29.52 | $16,120 | 199,061 (Indirect Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:13 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 825 | $29.52 | $24,357 | 83,664 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:12 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 364 | $29.52 | $10,747 | 70,251 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:10 pm | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer | 278 | $29.52 | $8,208 | 55,312 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:07 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 826 | $29.52 | $24,386 | 1,147,716 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:03 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 2,824 | $29.52 | $83,375 | 1,955,117 (Indirect Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:01 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 365 | $29.52 | $10,776 | 84,308 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:41 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,323 | $30.43 | $101,104 | 225,130 (Indirect Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:39 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 3,323 | $30.43 | $101,104 | 84,745 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:37 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 3,088 | $30.43 | $93,954 | 199,607 (Indirect Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:31 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 3,948 | $30.43 | $120,120 | 84,489 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:29 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,751 | $30.43 | $53,275 | 70,615 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:28 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 13,551 | $30.43 | $412,296 | 1,957,941 (Indirect Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:26 pm | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer | 1,291 | $30.43 | $39,279 | 55,590 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:25 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 3,948 | $30.43 | $120,120 | 1,148,542 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:23 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 1,396 | $30.43 | $42,474 | 84,673 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 3:19 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 1,096 | $30.43 | $33,346 | 48,138 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:14 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 2,201 | $29.96 | $65,938 | 228,453 (Indirect Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:12 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 2,201 | $29.96 | $65,938 | 88,068 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 1,730 | $29.96 | $51,828 | 202,695 (Indirect Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:09 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 2,145 | $29.96 | $64,260 | 88,437 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:07 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,241 | $29.96 | $37,178 | 72,366 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:04 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 6,007 | $29.96 | $179,959 | 1,971,492 (Indirect Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 750 | $29.96 | $22,469 | 1,152,490 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 3:59 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 1,235 | $29.96 | $36,998 | 86,069 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 3:56 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 715 | $29.96 | $21,420 | 49,234 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 3:54 pm | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 1,853 | $29.96 | $55,513 | 93,301 (Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:30 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 4,965 | $28.7 | $142,506 | 187,892 (Indirect Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:29 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 2,685 | $28.7 | $77,065 | 90,269 (Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:25 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 2,170 | $28.7 | $62,284 | 158,496 (Indirect Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:22 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 2,632 | $28.7 | $75,544 | 54,156 (Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,599 | $28.7 | $45,895 | 45,099 (Direct) | View |
| 2025-01-13 Sale | 2025-01-14 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 6,247 | $28.7 | $179,302 | 1,846,837 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-17 Option Award | 2025-04-21 4:23 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 16,483 | $0 | 44,678 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:23 pm | N/A 2032-04-17 | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 28,195 | $18.2 | 44,678 (Direct) | View |
| 2025-03-04 Gift | 2025-03-06 5:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 6,667 | $0 | 218,866 (Indirect) | View |
| 2025-01-21 Option Award | 2025-01-21 4:14 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 42,762 | $0 | 228,453 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 45,929 | $0 | 202,695 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 4:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 36,426 | $0 | 88,437 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 28,508 | $0 | 72,366 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 4:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 130,662 | $0 | 1,971,492 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 15,045 | $0 | 1,152,490 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 3:59 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 28,508 | $0 | 86,069 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 3:56 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 12,591 | $0 | 49,234 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-21 3:54 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 39,594 | $0 | 93,301 (Direct) | View |